Illumina Inc (USD)
ILMN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range317.44 | 326.00
52-Wk Range263.30 | 380.76
Last Close326.94
Mkt Cap (m)48,060.18
Dividend yield-
ISINUS4523271090
Volume799,258
Exchange VenueNAS

Company Profile

Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.

Key Information
Price/Earning49.99
Price/Book10.82
Price/Sales14.16
P/CF53.92
Rev Growth (3 year avg)14.51
EPS Growth (3 year avg)0.21
Operating Margin % 26.49
Net Margin %24.78
Return on Equity25.39
Debt/Equity0.53

Legal Documents

Annual Report
en 30/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)1,4211,8612,2202,3982,7523,333
Operating Income (m)254443623579606883
Net Income (m)125353462463726826
Basic EPS1.002.613.193.094.965.63
Avg. Diluted Shares Outstanding (m)140149149148148149
Balance Sheet
USD201320142015201620172018
Current Assets (m)1,6181,8902,0972,3182,9804,490
Non Current Assets (m)1,4011,4501,5911,9632,2772,469
Total Assets (m)3,0193,3403,6884,2815,2576,959
Current Liabilities (m)3227226107057461,804
Total Liabilities (m)------
Total Equity (m)1,5331,4631,8492,1972,7493,758
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)3865016606878751,142
Capital Expenditure (m)-91-142-143-271-312-296
Figures are quoted in USD unless stated otherwise
-6.37 (-1.95%)
$
320.57
Last Price